Live Nation Entertainment, Inc. vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Live Nation Entertainment, Inc. trades at $171.11 (market cap $39.80B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: Live Nation Entertainment, Inc. is far larger — about 17.5× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is more actively traded (3,128,960 versus 1,162,440). Which is the better fit depends on your goals.
| LYV | SLS | |
|---|---|---|
Market Cap | $39.80B | $2.28B |
Volume | 1,162,440 | 3,128,960 |
Sector | Media | Health |
52-Week High | $188.46 | $15.46 |
52-Week Low | $125.61 | $1.39 |
Typical Hold Time | 72 Days | — |
Enterprise Value | $42.01B | $2.15B |
Signals from Pluang's Aura AI — not financial advice
Live Nation Entertainment (LYV) trades at $171.34, down 0.26% on the day, with a bullish technical signal and strong analyst support (87% buy ratings). The company reported mixed Q2 2026 earnings with a beat on EPS but faces valuation concerns with a P/E of 117.5 and negative ROE of -116.7%. Recent news highlights strong consumer demand for live events and strategic partnerships, though regulatory scrutiny and insider selling warrant attention.
The outlook remains positive given robust fan attendance and deferred revenue growth, but high valuation and execution risks in a seasonally heavy Q4 present challenges. Wall Street's $208 price target suggests 21% upside, positioning LYV as a growth play on experiential spending trends with balanced risk-reward dynamics.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Live Nation is the largest live entertainment firm in the world with over 570 million fans served in 44 countries in 2018 by the company's concert and ticketing platforms. Via either owning, operating, or holding exclusive booking rights, Live Nation controls over 235 venues including the House of Blues, the Hollywood Palladium, and Spark Arena in New Zealand. Live Nation also owns one of the largest ticketing services, Ticketmaster, which sold over 480 million tickets for over 12,000 clients in 2018. The firm's artist management agencies have over 400 clients. This large live entertainment footprint helped Live Nation become one of the largest advertising and sponsorship platforms aimed at music fans. Liberty Media owns 33% of Live Nation, held under its SiriusXM tracking stock.
Read more on LYV →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →